| Product Name | MF | CAS | Details |
|---|
| Nicotine Related Compound A | C10H12N2 | 2743-90-0 | Details |
| Settleable Solids - WP | Details |
| Anti-LIMK2 antibody produced in rabbit | Details |
| Anti-CDK5RAP1, (N-terminal) antibody produced in rabbit | Details |
| N-(4-FLUOROBENZYLIDENE)-PARA-TOLUIDINE | C14H12FN | 39769-11-4 | Details |
| 2-AMINO-4-(2-NITRO-PHENYL)-5-OXO-5,6,7,8-TETRAHYDRO-4H-CHROMENE-3-CARBONITRILE | C16H13N3O4 | 315245-18-2 | Details |
| 2-Cyclohepten-1-one | C7H10O | 1121-66-0 | Details |
| LN6TF-C3-biot | Details |
| 2-(METHYLTHIO)BENZOXAZOLE | C8H7NOS | 13673-62-6 | Details |
| Mounting Kit | Details |
| PrEST Antigen TBC1D10B | Details |
| KL201 | C17H14BrN3OS | 302939-48-6 | Details |
| 1,4-Cyclohexanedimethanol divinyl ether, mixture of isomers | C12H20O2 | 17351-75-6 | Details |
| 5-Bromo-2-methoxybenzenesulfonyl chloride | C7H6BrClO3S | 23095-05-8 | Details |
| N'-[(E)-(5-BROMO-2-METHOXYPHENYL)METHYLIDENE]-2-(3-METHYL-5-OXO-4,5-DIHYDRO-1H-PYRAZOL-4-YL)ACETOHYDRAZIDE | C14H15BrN4O3 | 306952-54-5 | Details |
| ETHYL 8-BROMO-8-NITROOCTANOATE | C10H18BrNO4 | 13154-51-3 | Details |
| Cover for Milliflex Oasis VHP resistant pump, internal flow sanitization kit | Details |
| ANTI-SIGLEC15 (C-TERM) antibody produced in rabbit | Details |
| ORBO Tube Cutter | Details |
| 1-(4-ME-PH)-2-((4-(4-ME-PH)-5-(4-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL)THIO)ETHANONE | C23H20N4OS | 338426-00-9 | Details |
| 5-(4-CHLOROBENZYLIDENE)-2-PHENYL(1,3)THIAZOLO(3,2-B)(1,2,4)TRIAZOL-6(5H)-ONE | C17H10ClN3OS | 58755-11-6 | Details |
| 4-(2-((4-ETHYLANILINO)(OXO)ACETYL)CARBOHYDRAZONOYL)PHENYL 4-ETHOXYBENZOATE | C26H25N3O5 | 769148-49-4 | Details |
| Octaethylene glycol monohexadecyl ether | C32H66O9 | 5698-39-5 | Details |
| Monoclonal Anti-CTGF antibody produced in mouse | Details |
| 6-NITROCHOLESTERYL BENZOATE | C34H49NO4 | Details |
| 2-chloro-N-[(2E)-2-pyrrolidinylidene]-3-pyridinamine hydrochloride | Details |
| Monoclonal Anti-IL4, (C-terminal) antibody produced in mouse | Details |
| 4-(3-FLUORO-4-METHOXYBENZOYL)-3-HYDROXY-5-(4-PYRIDINYL)-1-(3-PYRIDINYLMETHYL)-1,5-DIHYDRO-2H-PYRROL-2-ONE | C23H18FN3O4 | 618074-69-4 | Details |
| Anti-A,B (clones ES-15/ES-4), Blood Grouping Reagent | Details |
| Hyocholic acid | C24H40O5 | 547-75-1 | Details |
| Diphenhydramine Citrate | C23H29NO8 | 88637-37-0 | Details |
| (2-(2-AMINOANILINO)-1-((4-ME-BENZOYL)AMINO)VINYL)(TRI-PH)PHOSPHONIUM PERCHLORATE | C34H31N3OP.ClO4 | 1265910-28-8 | Details |
| PrEST Antigen RTN2 | Details |
| Phospholipase C Activator, m-3M3FBS | C16H16F3NO2S | 200933-14-8 | Details |
| Anti-SPEN antibody produced in rabbit | Details |
| 1-(4-(4-Chlorobenzyloxy)-2-hydroxyphenyl)-2-(4-chlorophenyl)ethanone | C21H16Cl2O3 | 925007-31-4 | Details |
| 5-ALPHA-CHOLESTAN-1-BETA-OL | Details |
| N'-(2-FURYLMETHYLENE)-2-(2-THIENYL)ACETOHYDRAZIDE | C11H10N2O2S | 290366-55-1 | Details |
| hBFGF | NULL | 106096-93-9 | Details |
| Monoclonal Anti-AMID antibody produced in mouse | Details |
| N-(2-BROMOBENZYLIDENE)-4-(2,4-DIMETHYLBENZYL)-1-PIPERAZINAMINE | C20H24BrN3 | 315185-06-9 | Details |
| Park and Sanders Selective Supplement II | Details |
| ETHYL 6-(3-FLUOROPHENYL)-8-METHYL-4-OXO-3,4-DIHYDRO-2H,6H-PYRIMIDO[2,1-B][1,3]THIAZINE-7-CARBOXYLATE | C17H17FN2O3S | 618075-73-3 | Details |
| ETHYL 2-{[((2E)-2-{5-BROMO-2-[(4-ETHOXYBENZOYL)OXY]BENZYLIDENE}HYDRAZINO)(OXO)ACETYL]AMINO}-6-METHYL-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXYLATE | C30H30BrN3O7S | 883569-02-6 | Details |
| Anti-phospho-PKD2 (pSer876) antibody produced in rabbit | Details |
| Anti-SSRP1 antibody produced in rabbit | Details |
| 2-F-N-(2,2,2-TRICHLORO-1-(3-(2-CL-5-TRIFLUORO-ME-PH)-THIOUREIDO)-ET)-ACETAMIDE | 301813-60-5 | Details |
| 1-(2-(DIMETHYLAMINO)ETHYL)-3-PHENYL-2,4,5-IMIDAZOLIDINETRIONE | C13H15N3O3 | 883799-33-5 | Details |
| Anti-PGK1 antibody produced in rabbit | Details |
| 3-Bromo-5-(2-hydroxyethyl)isoxazole | C5H6BrNO2 | 105175-00-6 | Details |
| 1-DODECYLOXYCARBONYLMETHYL-3-(METHYLCARBAMOYL)-PYRIDINIUM CHLORIDE | C21H35ClN2O3 | 112746-29-9 | Details |
| N-(2-(2-(4-(DIMETHYLAMINO)BENZYLIDENE)HYDRAZINO)-2-OXOETHYL)-4-FLUOROBENZAMIDE | C18H19FN4O2 | 324032-47-5 | Details |
| 1-(5-Methyl-1H-pyrazol-4-yl)ethanone | C6H8N2O | 105224-04-2 | Details |
| 1-(5-nitro-2-thienyl)piperidine | C9H12N2O2S | 19991-84-5 | Details |
| 4-ETHOXYBENZALDEHYDE [1,3-DIMETHYL-7-(4-METHYLBENZYL)-2,6-DIOXO-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL]HYDRAZONE | C24H26N6O3 | 536718-58-8 | Details |
| 5-FLUORO-2-(4-FLUORO-BENZYL)-ISOINDOLE-1,3-DIONE | C15H9F2NO2 | 351996-28-6 | Details |
| (METHOXYCARBONYLAMINO-(4-METHOXY-PHENYL)-METHYL)-CARBAMIC ACID METHYL ESTER | C12H16N2O5 | 303061-60-1 | Details |
| Xanthene | C13H10O | 92-83-1 | Details |
| Anti-ORAI2 antibody produced in rabbit | Details |
| 9-CHLORO-2-(4-CHLOROPHENYL)-1,10B-DIHYDROSPIRO[BENZO[E]PYRAZOLO[1,5-C][1,3]OXAZINE-5,1'-CYCLOHEXANE] | 332060-48-7 | Details |
| Anti-ZKSCAN4 antibody produced in rabbit | Details |
| 4-(2,4-DIMETHYLPHENYL)-5-PHENYL-4H-1,2,4-TRIAZOLE-3-THIOL | C16H15N3S | 334501-13-2 | Details |
| 1-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-N'-[(Z)-1-[1,1'-BIPHENYL]-4-YLETHYLIDENE]-5-[(2-METHYL-1-PIPERIDINYL)METHYL]-1H-1,2,3-TRIAZOLE-4-CARBOHYDRAZIDE HYDROCHLORIDE | C26H29N9O2.ClH | 1173010-95-1 | Details |
| ISOPROPYL 5-(9H-PURIN-6-YLTHIO)PENTANOATE | 10389-90-9 | Details |
| 1-((1S,5R)-5-{[TERT-BUTYL(DIPHENYL)SILYL]OXY}-2-CYCLOPENTEN-1-YL)-3-PENTYN-2-OL | C26H32O2Si | 1217521-49-7 | Details |
| Anti-EIF4E3 antibody produced in rabbit | Details |
| 1-[2-(DIETHYLAMINO)ETHYL]-3-HYDROXY-5-(4-HYDROXY-3-METHOXYPHENYL)-4-(4-ISOBUTOXY-2-METHYLBENZOYL)-1,5-DIHYDRO-2H-PYRROL-2-ONE | C29H38N2O6 | 488706-66-7 | Details |
| N-(3-CHLORO-4-METHYLPHENYL)-2-{[5-(4-CHLOROPHENYL)-4-(4-METHYLPHENYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}ACETAMIDE | C24H20Cl2N4OS | 477330-99-7 | Details |
| 4-(2-((1-NAPHTHYLOXY)ACETYL)CARBOHYDRAZONOYL)PHENYL 3-BROMOBENZOATE | C26H19BrN2O4 | 302910-43-6 | Details |
| Anti-ANKRD24 antibody produced in rabbit | Details |
| RCL S120138 | 1037840-20-2 | Details |
| 2-{[4-ALLYL-5-(2-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL}-N-[4-(DIETHYLAMINO)PHENYL]ACETAMIDE | C22H26N6OS | 618880-20-9 | Details |
| N-((2-ETHOXY-1-NAPHTHYL)METHYLENE)-2-ETHYLANILINE | C21H21NO | 1429788-68-0 | Details |
| 4-isopropylbenzohydrazide | C10H14N2O | 5351-24-6 | Details |
| 6-METHYL-7-PHENYL-5H-PYRROLO[2,3-B]PYRAZINE | C13H11N3 | 56015-25-9 | Details |
| Clozapine N-oxide hydrochloride | C18H19ClN4O | 34233-69-7 | Details |
| Corning LSE Digital Vortexer Platform For Four Microplates | Details |
| 5-NAPHTHALEN-2-YL-2H-PYRAZOLE-3-CARBOXYLIC ACID (3-PHENYL-ALLYLIDENE)-HYDRAZIDE | C23H18N4O | 306301-85-9 | Details |
| Methyltrioctylammonium chloride | C25H54N.Cl | 5137-55-3 | Details |
| Anti-ITGA8 antibody produced in rabbit | Details |
| Aluminum cerium oxide | AlCeO3 | 12014-44-7 | Details |
| Anti-PHACTR2 antibody produced in rabbit | Details |
| Anti-Potassium Channel TREK-1 Antibody | Details |
| 2(4,5-DI-PH-4H(1,2,4)TRIAZOL-3-YLSULFANYL)ACETIC ACID (1-PH-ETHYLIDENE)HYDRAZIDE | C24H21N5OS | 303204-65-1 | Details |
| TAO1 Protein, active, 10 μg | Details |
| 2,4,6-Trimethylaniline | C9H13N | 88-05-1 | Details |
| 1,2-di(1H-benzimidazol-2-yl)-1,2-ethanediol | C16H14N4O2 | 3314-32-7 | Details |
| 2-CL-N'-(4-MEO-3-((3-NITRO-1H-1,2,4-TRIAZOL-1-YL)ME)BENZYLIDENE)BENZOHYDRAZIDE | C18H15ClN6O4 | 883826-07-1 | Details |
| 5-Lipoxygenase, Human, Recombinant, S. fruigiperda | Details |
| 2-IMINO-N-(3-METHOXYPROPYL)-10-METHYL-1-[2-(4-MORPHOLINYL)ETHYL]-5-OXO-1,5-DIHYDRO-2H-DIPYRIDO[1,2-A:2,3-D]PYRIMIDINE-3-CARBOXAMIDE | C23H30N6O4 | 618383-67-8 | Details |
| SCHU human cell line | Details |
| N-(4-SEC-BUTYLPHENYL)-2-FURAMIDE | 329939-27-7 | Details |
| Anti-Rabbit set(AP187P/2170/WBKL500ml | Details |
| RCL L210277 | C19H18N2O3 | 1005189-03-6 | Details |
| 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine | C15H14N4 | 32515-07-4 | Details |
| MScn Vac Mnfld Pump Kit-100V,50-60Hz | Details |
| ETHYL 4-METHYL-2-{[(1-NAPHTHYLOXY)ACETYL]AMINO}-5-(2-TOLUIDINOCARBONYL)-3-THIOPHENECARBOXYLATE | C28H26N2O5S | 518349-83-2 | Details |
| ETHYL 5-{[(3-ALLYL-4-OXO-5-PHENYL-3,4-DIHYDROTHIENO[2,3-D]PYRIMIDIN-2-YL)SULFANYL]ACETYL}-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXYLATE | C26H25N3O4S2 | 315710-53-3 | Details |
| (2-ALLYLCYCLOHEXYLIDENE)ACETIC ACID, CYCLOHEXYLAMINE SALT | 111946-01-1 | Details |
| N'-(4-HO-3-METHOXYBENZYLIDENE)-3-(4-ISOBUTYLPHENYL)-1H-PYRAZOLE-5-CARBOHYDRAZIDE | C22H24N4O3 | 403659-35-8 | Details |
| Product Total： Product Page： | ||||
| 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 | ||||